R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The power and potential of regenerative medicine

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founde

R&D

Changing Faces: Pharma and biotech hires from April 2024

Coming to you well over a month late, we still want to acknowledge the many comings and goings we saw in the biotech industry in April.

R&D

Veeva R&D and Quality 2024: Chris Moore

During the Veeva R&D and Quality Summit held in Madrid last month, web editor Nicole Raleigh sat down with Chris Moore, president of Europe for Veeva Systems, to discuss the event and i

R&D

The future of fertility and the vaginal microbiome

As societies have modernised, fertility rates have declined substantially.

R&D

Generative AI in clinical trials: Practical use cases and co...

With the hype around generative AI (GenAI), there is an increasing demand to explore its capabilities across pharma and MedTech companies, as well as contract research organisations.

R&D